C0079189||Cytokine
C0085295||IL-10
C0751968||activators
C0044602||PI3-kinase
C0243192||agonists
C0034783||Î±-2 adrenoreceptor
C0003402||antioxidants
C0022116||ischemia
C0007587||cell death
C0034693||rat
C0019564||hippocampal
C0079189||cytokine
C0085295||IL-10
C0044602||PI3-kinase
C0751968||selective activator
C1254351||740 Y-P
C0243192||selective agonists
C0034783||alpha-2 adrenoreceptor
C0079466||guanfacine
C0147760||UK-14,304
C1254351||compounds
C3179302||antioxidant effect
C1873178||human peroxiredoxin 6
C1254351||B27
C0019564||hippocampal
C4236780||during OGD
C4236780||response of cells to OGD
C0600430||spontaneous synchronous Ca(2+)-oscillations
C0600430||spontaneous synchronous Ca(2+)-oscillations
C0027882||neurons
C0596235||Ca(2+)
C0391850||pulse
C0004112||astrocytes
C0596235||Ca(2+)
C0004112||astrocytes
C0022116||ischemia
C0243095||disappeared
C4236780||after a few minutes of OGD
C0243095||sharp/avalanche
C0243095||global synchronic
C0596235||Ca(2+)
C0007634||cells
C4236780||after OGD
C0007587||mass death of cells
C0004112||astrocytes
C1254351||compounds
C0007634||cells
C1439852||incubated
C0242912||neuroprotective agents
C0022116||ischemia
C0242912||neuroprotective agents
C0596235||Ca(2+)
C4236780||during OGD
C0007620||cell survival